Log In Sign Up

Predicting Clinical Trial Results by Implicit Evidence Integration

by   Qiao Jin, et al.

Clinical trials provide essential guidance for practicing Evidence-Based Medicine, though often accompanying with unendurable costs and risks. To optimize the design of clinical trials, we introduce a novel Clinical Trial Result Prediction (CTRP) task. In the CTRP framework, a model takes a PICO-formatted clinical trial proposal with its background as input and predicts the result, i.e. how the Intervention group compares with the Comparison group in terms of the measured Outcome in the studied Population. While structured clinical evidence is prohibitively expensive for manual collection, we exploit large-scale unstructured sentences from medical literature that implicitly contain PICOs and results as evidence. Specifically, we pre-train a model to predict the disentangled results from such implicit evidence and fine-tune the model with limited data on the downstream datasets. Experiments on the benchmark Evidence Integration dataset show that the proposed model outperforms the baselines by large margins, e.g., with a 10.7 relative gain over BioBERT in macro-F1. Moreover, the performance improvement is also validated on another dataset composed of clinical trials related to COVID-19.


page 1

page 2

page 3

page 4


Predicting Intervention Approval in Clinical Trials through Multi-Document Summarization

Clinical trials offer a fundamental opportunity to discover new treatmen...

Attention-Based LSTM Network for COVID-19 Clinical Trial Parsing

COVID-19 clinical trial design is a critical task in developing therapeu...

Validating GAN-BioBERT: A Methodology For Assessing Reporting Trends In Clinical Trials

In the past decade, there has been much discussion about the issue of bi...

Evidence Inference 2.0: More Data, Better Models

How do we most effectively treat a disease or condition? Ideally, we cou...

Trial2Vec: Zero-Shot Clinical Trial Document Similarity Search using Self-Supervision

Clinical trials are essential for drug development but are extremely exp...

A bayesian reanalysis of the phase III aducanumab (ADU) trial

In this article we have conducted a reanalysis of the phase III aducanum...

Local Explanations for Clinical Search Engine results

Health care professionals rely on treatment search engines to efficientl...